AbCellera to share phase 1 data for menopause treatment during earnings

April 20, 2026 9:00 AM

AbCellera Biologics Inc. (NASDAQ: ABCL) announced it will disclose interim results from the Phase 1 portion of its ABCL635 study ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found